News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,225 Results
Type
Article (87774)
Company Profile (824)
Press Release (778611)
Multimedia
Podcasts (187)
Webinars (28)
Section
Business (233175)
Career Advice (4144)
Deals (39839)
Drug Delivery (144)
Drug Development (91362)
Employer Resources (203)
FDA (18359)
Job Trends (17415)
News (397724)
Policy (39949)
Tag
Academia (3006)
Academic (2)
Accelerated approval (26)
Adcomms (35)
Allergies (135)
Alliances (56981)
ALS (171)
Alzheimer's disease (1762)
Antibody-drug conjugate (ADC) (309)
Approvals (18478)
Artificial intelligence (582)
Autoimmune disease (136)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (191)
Biotechnology (488)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (626)
Cancer (4725)
Cardiovascular disease (410)
Career advice (3566)
Career pathing (40)
CAR-T (291)
CDC (59)
Celiac Disease (1)
Cell therapy (789)
Cervical cancer (37)
Clinical research (76596)
Collaboration (1617)
Company closure (5)
Compensation (1075)
Complete response letters (65)
COVID-19 (2980)
CRISPR (93)
C-suite (751)
Cystic fibrosis (148)
Data (5883)
Decentralized trials (2)
Denatured (68)
Depression (133)
Diabetes (498)
Diagnostics (7176)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (276)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (227)
Earnings (99899)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134551)
Executive appointments (1010)
FDA (21242)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1445)
Gene editing (202)
Generative AI (60)
Gene therapy (628)
GLP-1 (1085)
Government (5421)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (277)
Immuno-oncology (42)
Indications (77)
Infectious disease (3251)
Inflammatory bowel disease (198)
Inflation Reduction Act (16)
Influenza (112)
Intellectual property (218)
Interviews (816)
IPO (17943)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10154)
Liver cancer (95)
Longevity (14)
Lung cancer (650)
Lymphoma (361)
Machine learning (40)
Management (66)
Manufacturing (754)
MASH (166)
Medical device (14972)
Medtech (15012)
Mergers & acquisitions (22882)
Metabolic disorders (1300)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (323)
Neuropsychiatric disorders (86)
Neuroscience (2966)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (624)
Opinion (327)
Ovarian cancer (153)
Pain (192)
Pancreatic cancer (204)
Parkinson's disease (273)
Partnered (34)
Patents (471)
Patient recruitment (414)
Peanut (59)
People (66651)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23654)
Phase II (33241)
Phase III (25061)
Pipeline (3959)
Policy (319)
Postmarket research (3554)
Preclinical (10669)
Press Release (72)
Prostate cancer (230)
Psychedelics (53)
Radiopharmaceuticals (290)
Rare diseases (811)
Real estate (7436)
Recruiting (80)
Regulatory (28597)
Reports (65)
Research institute (2716)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (241)
Series B (177)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (97)
The Weekly (117)
Vaccines (1108)
Venture capital (81)
Weight loss (434)
Women's health (79)
Worklife (21)
Date
Today (126)
Last 7 days (606)
Last 30 days (2613)
Last 365 days (33360)
2025 (32761)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (327)
Arkansas (14)
Asia (51342)
Australia (9019)
California (10865)
Canada (3176)
China (1067)
Colorado (457)
Connecticut (481)
Delaware (328)
Europe (118003)
Florida (1591)
Georgia (351)
Hawaii (3)
Idaho (68)
Illinois (896)
India (62)
Indiana (524)
Iowa (22)
Japan (384)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1397)
Massachusetts (8042)
Michigan (343)
Minnesota (630)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (27)
Nevada (118)
New Hampshire (81)
New Jersey (2958)
New Mexico (32)
New York (2901)
North Carolina (1539)
North Dakota (10)
Northern California (5126)
Ohio (331)
Oklahoma (22)
Oregon (52)
Pennsylvania (2200)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4175)
Tennessee (168)
Texas (1708)
United States (39500)
Utah (325)
Vermont (1)
Virginia (274)
Washington D.C. (85)
Washington State (919)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
There are 867,225 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma
December 18, 2025
·
5 min read
Press Releases
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
December 18, 2025
·
1 min read
Press Releases
ProFound Therapeutics Strengthens Leadership Team with Tom Chittenden as Chief Technology Officer and Laurel Ostrom as Chief Human Resources Officer
December 18, 2025
·
3 min read
Press Releases
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy
December 18, 2025
·
5 min read
Layoffs
Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs
Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last month. Projects under the deal for spinal muscular atrophy and Huntington’s disease continue to advance.
December 18, 2025
·
2 min read
·
Tristan Manalac
Collaboration
GSK Makes $400M+ RNA Play With CAMP4 Collab, Targets Neuro, Kidney Diseases
The Massachusetts biotech will also be eligible to milestone payments, though the exact amount has yet to be disclosed.
December 18, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Confo Therapeutics Nominates SSTR5 Agonist Antibody CFTX-2034 as Development Candidate for Post-Bariatric Hypoglycemia
December 18, 2025
·
4 min read
Press Releases
MUVON Therapeutics Appoints Dr. Christine Günther as Chief Technology Officer
December 18, 2025
·
4 min read
Press Releases
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
December 18, 2025
·
7 min read
Press Releases
Orum Therapeutics Secures Approximately US$100 Million to Accelerate Development of Leading Degrader Antibody Conjugate Programs to Treat Serious Diseases
December 18, 2025
·
5 min read
1 of 86,723
Next
